Duloxetine-induced ultrarapid cycling in an adolescent with bipolar depression [18]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 1, 2007, Pages 115-116

  Desarkar, Pushpal ^a   Bakhla, Ajay ^a   Sinha, Vinod Kumar ^a  

^a CENTRAL INSTITUTE OF PSYCHIATRY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; MONOAMINE OXIDASE INHIBITOR; OLANZAPINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ADOLESCENT; BIPOLAR DEPRESSION; CASE REPORT; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FAMILY HISTORY; FEMALE; FOLLOW UP; FUNCTION TEST; GENERAL PRACTITIONER; HUMAN; HYPOMANIA; LABORATORY TEST; LETTER; MAJOR DEPRESSION; MANIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PSYCHIATRIST; RAPID CYCLING BIPOLAR DISORDER;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; EUPHORIA; FEMALE; HUMANS; PERIODICITY; THIOPHENES;

EID: 33846232610     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31802e7573     Document Type: Letter

References (7)

1. Wolpert EA, Goldberg JF, Harrow M. Rapid cycling in unipolar and bipolar affective disorders. Am J Psychiatry. 1990;147:725-728.
2. Kilzieh N, Akiskal HS. Rapid-cycling bipolar disorder: an overview of recent research and clinical experience. Psychiatr Clin North Am. 1999;22:585-587.
3. Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry. 1994;164:549-550.
4. Gupta N. Venlafaxine-induced hypomanic switch in bipolar depression. Can J Psychiatry. 2001;46:760-761.
5. Chand PK, Kalyani GS, Murthy P. Venlafaxine-associated hypomania in unipolar depression. Can J Psychiatry. 2004;49:496
6. Dunner DL, D'Souza DN, Kajdasz DK, et al. Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression. J Affect Disord. 2005;87:115-119.
7. Schatzberg AF. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder. J Clin Psychiatry. 2003;64:30-37.